We observed a marked and progressive raise in both MPO (+150%; P < .01, +372; P < .001 and +706%; P < .001) and MDA levels (+263%; P < .01; +516%; P < .001 and +988%; P < .001) (Figure 1C) in peritumoral, UC and cancer specimens vs controls. The gene discussed is MPO; the disease is cancer.